Overview

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This is a trial in obese subjects who have poor lipid control with and without Type 2 diabetes mellitus to study the safety, tolerability and pharmacokinetics of multiple doses of PF-05231023
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer